,outcome,arm 1,arm 2
0,intervention,pioglitazone,glimepirede
0,"intent-to-treat, HbA ( 1c ), end of the study, baseline",-0.78 %,NR
0,"HbA ( 1c ), end of the study",NR,-0.68 %
